 Connection
Matthew Greenhawt to United Kingdom
This is a "connection" page, showing publications Matthew Greenhawt has written about United Kingdom.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.445 |
|
|
|
-
Shaker M, Abrams EM, Greenhawt M. A Cost-Effectiveness Evaluation of Hospitalizations, Fatalities, and Economic Outcomes Associated with Universal Versus Anaphylaxis Risk-Stratified COVID-19 Vaccination Strategies. J Allergy Clin Immunol Pract. 2021 07; 9(7):2658-2668.e3.
Score: 0.172
-
Shaker M, Stukus D, Chan ES, Fleischer DM, Spergel JM, Greenhawt M. "To screen or not to screen": Comparing the health and economic benefits of early peanut introduction strategies in five countries. Allergy. 2018 Aug; 73(8):1707-1714.
Score: 0.142
-
Chong AC, Diwakar L, Kaplan CM, Fox AT, Abrams EM, Greenhawt M, Oppenheimer JJ, Shaker MS. Provision of Food Allergy Care in the United Kingdom and United States: Current Issues and Future Directions. J Allergy Clin Immunol Pract. 2023 07; 11(7):2054-2066.
Score: 0.050
-
Bansal P, Bingemann TA, Greenhawt M, Mosnaim G, Nanda A, Oppenheimer J, Sharma H, Stukus D, Shaker M. Reply to "Challenges to pediatric services during COVID-19 pandemic: A?London, UK perspective". J Allergy Clin Immunol Pract. 2020 09; 8(8):2835-2836.
Score: 0.041
-
Deniskin R, Fleischer D, Greenhawt M, Fox AT, Anagnostou A. Differences in the evaluation of skin prick testing results for food allergy diagnosis between US and UK physicians. J Allergy Clin Immunol Pract. 2020 10; 8(9):3237-3239.
Score: 0.041
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|